PXK antibody [N2C2], Internal
Not tested in other applications.
*Optimal dilutions/concentrations should be determined by the researcher.
|Predicted Target Size||65 kDa (note)
|Positive Controls||A431 , H1299 , HeLa , HepG2 , Raji , mouse brain|
(Please refer to the vial label for the specific concentration)|
|Purification||Purified by antigen-affinity chromatography.|
|Full Name||PX domain containing serine/threonine kinase|
|Product Description||Rabbit Polyclonal antibody to PXK (PX domain containing serine/threonine kinase)|
|Background||PXK binds to the Na,K-ATPase beta-1 (ATP1B1; MIM 182330) and beta-3 (ATP1B3; MIM 601867) subunits and modulates both Na,K-ATPase enzymatic and ion pump activities (Mao et al., 2005 [PubMed 16135750]).[supplied by OMIM]|
|Synonyms||FLJ20335 antibody, MONaKA antibody, PXK antibody, PX ser/thr kinase v2 antibody, "modulator of Na,K-ATPase long form antibody", PX domain-containing protein kinase-like protein antibody, PX serine/threonine kinase antibody, PX domain containing serine/threonine kinase antibody|
|Cellular Localization||Cytoplasm , Cell membrane; Peripheral membrane protein |
|Immunogen||Recombinant protein encompassing a sequence within the center region of human PXK. The exact sequence is proprietary.|
|Species Reactivity||Human, Mouse|
|Predicted Cross Reactivity species Predicted cross-reactivity:|
Predicted cross-reactivity is based on sequence homology, with greater than 80% immunogen sequence identity considered positive.
Please note that we are only able to guarantee products to work in applications and species in which they have been tested.
|Predict Reactivity Note||Rat (96%), Bovine (98%)|